CoChat

SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats

Open access
Thomas, David R, Melotto, Sergio, Massagrande, Mario, Gribble, Andrew D, Jeffrey, Phillip, Stevens, Alexander J, Deeks, Nigel J, Eddershaw, Peter J, Fenwick, Susan H, Riley, Graham, Stean, Tania, Scott, Claire M, Hill, Matthew J, Middlemiss, Derek N, Hagan, Jim J, Price, Gary W, Forbes, Ian T · 2003 · British Journal of Pharmacology
Cited by 127

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

(6‐((R)‐2‐{2‐[4‐(4‐Chloro‐phenoxy)‐piperidin‐1‐yl]‐ethyl}‐pyrrolidine‐1‐sulphonyl)‐1H‐indole hydrochloride) (SB‐656104‐A), a novel 5‐hydroxytryptamine (5‐HT 7) receptor antagonist, potently inhibited [3 H]‐SB‐269970 binding to the human cloned 5‐HT 7(a) (p Ki 8.7±0.1) and 5‐HT 7(b) (p Ki 8.5±0.2) receptor variants and the rat native receptor (p Ki 8.8±0.2). The compound displayed at least 30‐fold selectivity for the human 5‐HT 7(a) receptor versus other human cloned 5‐HT receptors apart from the 5‐HT 1D receptor (∼10‐fold selective). SB‐656104‐A antagonised competitively the 5‐carboxamidotryptamine (5‐CT)‐induced accumulation of cyclic AMP in h5‐HT 7(a)/HEK293 cells with a pA 2 of 8.5. Following a constant rate iv infusion to steady state in rats, SB‐656104 had a blood clearance (CL b) of 58±6 ml min−1 kg−1 and was CNS penetrant with a steady‐state brain : blood ratio of 0.9 : 1. Following i.p. administration to rats (10 mg kg−1), the compound displayed a t1/2 of 1.4 h with mean brain and blood concentrations (at 1 h after dosing) of 0.80 and 1.0 μM, respectively. SB‐656104‐A produced a significant reversal of the 5‐CT‐induced hypothermic effect in guinea pigs, a pharmacodynamic model of 5‐HT 7 receptor interaction in vivo (ED 50 2 mg kg−1). SB‐656104‐A, administered to rats at the beginning of the sleep period (CT 0), significantly increased the latency to onset of rapid eye movement (REM) sleep at 30 mg kg−1 i.p. (+93%) and reduced the total amount of REM sleep at 10 and 30 mg kg−1 i.p. with no significant effect on the latency to, or amount of, non‐REM sleep. SB‐269970‐A produced qualitatively similar effects in the same study. In summary, SB‐656104‐A is a novel 5‐HT 7 receptor antagonist which has been utilised in the present study to provide further evidence for a role for 5‐HT 7 receptors in the modulation of REM sleep. British Journal of Pharmacology (2003) 139, 705–714. doi:10.1038/sj.bjp.0705290

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0705290

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 127

Metadata

Authors
Thomas, D. R., Melotto, S., Massagrande, M., Gribble, A. D., Jeffrey, P., Stevens, A. J., Deeks, N. J., Eddershaw, P. J., Fenwick, S. H., Riley, G., Stean, T., Scott, C. M., Hill, M. J., Middlemiss, D. N., Hagan, J. J., Price, G. W., & Forbes, I. T.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2003-06
Volume
139
Issue
4
Pages
705-714
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2048995786
Cited by
127
References
5
FWCI
2.75
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats. https://app.cochat.ai/papers/10.1038/sj.bjp.0705290
The paper
Thomas, D. R., Melotto, S., Massagrande, M., Gribble, A. D., Jeffrey, P., Stevens, A. J., Deeks, N. J., Eddershaw, P. J., Fenwick, S. H., Riley, G., Stean, T., Scott, C. M., Hill, M. J., Middlemiss, D. N., Hagan, J. J., Price, G. W., & Forbes, I. T. (2003). SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0705290

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.